<DOC>
	<DOCNO>NCT00469768</DOCNO>
	<brief_summary>IPM 018 double-blind , randomize , placebo-controlled study conduct one site Belgium among 24 healthy , HIV-negative woman evaluate dapivirine release 28 day matrix reservoir intravaginal ring , contain 25 mg dapivirine , assess safety tolerability compare placebo</brief_summary>
	<brief_title>A Pharmacokinetic Study Dapivirine Vaginal Rings Belgium</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Women 18 35 year age Willing able give write informed consent Available visit consent follow procedure schedule study Healthy HIVnegative determine HIV1 ELISA test time enrollment ; Willing abstain sexual activity duration study Willing use oral contraceptive avoid menstruation take part study longacting progestin 6 month prior enrollment Upon pelvic / speculum examination enrollment , cervix vagina appear normal Willing refrain use vaginal product object duration study . History alcoholism , drug abuse , psychosis , antagonistic personality , poor motivation , emotional intellectual problem likely invalidate inform consent process adversely impact compliance protocol requirement ; History sensitivity / allergy latex , dapivirine constituent vaginal ring ( i.e . silicone elastomer ) Currently pregnant breastfeeding , within three month last pregnancy outcome Currently within one month participate clinical research study History diagnosis / treatment sexually transmit disease within last three month History genital tract surgery within last month Current diagnosis sexually transmit infection ( Gonorrhea , Chlamydia Trichomonas ) Current vulvar vaginal symptom / abnormality could influence study result History significant urogenital uterine prolapse , undiagnosed vaginal bleeding urethral obstruction within last three month ; Smoking 10 cigarette per day</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>HIV-1 infection</keyword>
	<keyword>HIV Seronegativity</keyword>
</DOC>